Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin-31 is a cell-surface transmembrane protein with four hydrophobic domains, belonging to the tetraspanin family, and is involved in numerous cellular processes such as signal transduction, proliferation, migration, and survival. It plays important roles in cancer biology, including osteosarcoma, gastric cancer, and hepatocellular carcinoma, by promoting tumor growth, motility, and suppressing apoptosis. TSPAN31 is also implicated in regulating key signaling pathways (e.g., AKT/GSK-3β/β-catenin, PI3K/Akt), and its increased expression is associated with aggressive tumor behavior and poor patient outcomes[1][2][3][4]. No approved drugs specifically target TSPAN31 yet, but its biomarker potential and mechanistic relevance in cancer make it an attractive target for ongoing research.
Inhibition of TSPAN31 or its gene silencing can suppress tumor cell proliferation, migration, and invasion, and induce apoptosis, likely through disruption of signaling pathways such as PI3K/Akt and the AKT/GSK-3β/β-catenin axis[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin-31 (TSPAN31).